Computed tomography dose optimisation in cystic fibrosis: A review.

dc.contributor.authorFerris, Helena
dc.contributor.authorTwomey, Maria
dc.contributor.authorMoloney, Fiachra
dc.contributor.authorO'Neill, Siobhán B.
dc.contributor.authorMurphy, Kevin P.
dc.contributor.authorO'Connor, Owen J.
dc.contributor.authorMaher, Michael M.
dc.date.accessioned2018-04-25T14:48:41Z
dc.date.available2018-04-25T14:48:41Z
dc.date.issued2016-04-28
dc.date.updated2018-04-23T16:25:04Z
dc.description.abstractCystic fibrosis (CF) is the most common autosomal recessive disease of the Caucasian population worldwide, with respiratory disease remaining the most relevant source of morbidity and mortality. Computed tomography (CT) is frequently used for monitoring disease complications and progression. Over the last fifteen years there has been a six-fold increase in the use of CT, which has lead to a growing concern in relation to cumulative radiation exposure. The challenge to the medical profession is to identify dose reduction strategies that meet acceptable image quality, but fulfil the requirements of a diagnostic quality CT. Dose-optimisation, particularly in CT, is essential as it reduces the chances of patients receiving cumulative radiation doses in excess of 100 mSv, a dose deemed significant by the United Nations Scientific Committee on the Effects of Atomic Radiation. This review article explores the current trends in imaging in CF with particular emphasis on new developments in dose optimisation.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationFerris, H., Twomey, M., Moloney, F., O’Neill, S. B., Murphy, K. P., O’Connor, O. J. and Maher, M. M. (2016) 'Computed tomography dose optimisation in cystic fibrosis: A review', World Journal of Radiology: WJR, 8(4) pp. 331-341. doi:10.4329/wjr.v8.i4.331en
dc.identifier.doi10.4329/wjr.v8.i4.331
dc.identifier.endpage341en
dc.identifier.issn1949-8470
dc.identifier.issued4en
dc.identifier.journaltitleWorld Journal of Radiology: WJRen
dc.identifier.startpage331en
dc.identifier.urihttps://hdl.handle.net/10468/5876
dc.language.isoenen
dc.publisherBaishideng Publishing Groupen
dc.rights© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/ licenses/by-nc/4.0/en
dc.rights.urihttp://creativecommons.org/ licenses/by-nc/4.0/en
dc.subjectCystic fibrosisen
dc.subjectDose optimizationen
dc.subjectComputed tomographyen
dc.subjectDoseen
dc.subjectIonising radiationen
dc.subjectKalydecoen
dc.subjectlow dose CTen
dc.subjectCT dose reductionen
dc.titleComputed tomography dose optimisation in cystic fibrosis: A review.en
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
h_ferris_ct_dose_optimisation_in_cf.pdf
Size:
900.38 KB
Format:
Adobe Portable Document Format
Description:
Published version
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description: